AC009041.2 | | | | | | | Not detected |
SOX8 | SRY (sex determining region Y)-box 8 | Transcription factors
| | | | | Tissue enriched |
SSTR5 | Somatostatin receptor 5 | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Not detected |
C1QTNF8 | C1q and tumor necrosis factor related protein 8 | Predicted secreted proteins
| | | | | Not detected |
CACNA1H | Calcium channel, voltage-dependent, T type, alpha 1H subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
TPSG1 | Tryptase gamma 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
TPSAB1 | Tryptase alpha/beta 1 | Enzymes Predicted secreted proteins
| | | | | Mixed |
TPSD1 | Tryptase delta 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
UBE2I | Ubiquitin-conjugating enzyme E2I | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
BAIAP3 | BAI1-associated protein 3 | | | | | | Tissue enhanced |
TSR3 | TSR3, 20S rRNA accumulation, homolog (S. cerevisiae) | | | | | | Expressed in all |
GNPTG | N-acetylglucosamine-1-phosphate transferase, gamma subunit | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
UNKL | Unkempt family zinc finger-like | | | | | | Expressed in all |
C16orf91 | Chromosome 16 open reading frame 91 | Predicted membrane proteins
| | | | | Expressed in all |
CCDC154 | Coiled-coil domain containing 154 | | | | | | Tissue enhanced |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PTX4 | Pentraxin 4, long | Predicted secreted proteins
| | | | | Not detected |
TELO2 | Telomere maintenance 2 | Predicted membrane proteins
| | | | | Expressed in all |
IFT140 | Intraflagellar transport 140 homolog (Chlamydomonas) | Disease related genes
| | | | | Expressed in all |
TMEM204 | Transmembrane protein 204 | Predicted membrane proteins
| | | | | Mixed |
CRAMP1L | Crm, cramped-like (Drosophila) | Transcription factors
| | | | | Expressed in all |
LA16c-431H6.6 | | | | | | | Not detected |
HN1L | Hematological and neurological expressed 1-like | | | | | | Expressed in all |
MAPK8IP3 | Mitogen-activated protein kinase 8 interacting protein 3 | | | | | | Expressed in all |
NME3 | NME/NM23 nucleoside diphosphate kinase 3 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
MRPS34 | Mitochondrial ribosomal protein S34 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
EME2 | Essential meiotic structure-specific endonuclease subunit 2 | | | | | | Expressed in all |
SPSB3 | SplA/ryanodine receptor domain and SOCS box containing 3 | | | | | | Expressed in all |
NUBP2 | Nucleotide binding protein 2 | | | | | | Expressed in all |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HAGH | Hydroxyacylglutathione hydrolase | Enzymes Plasma proteins
| | | | | Expressed in all |
FAHD1 | Fumarylacetoacetate hydrolase domain containing 1 | Enzymes
| | | | | Expressed in all |
MEIOB | Meiosis specific with OB domains | | | | | | Tissue enriched |
HS3ST6 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 6 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MSRB1 | Methionine sulfoxide reductase B1 | | | | | | Expressed in all |
RPL3L | Ribosomal protein L3-like | Ribosomal proteins
| | | | | Group enriched |
NDUFB10 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa | Mitochondrial proteins
| | | | | Expressed in all |
RPS2 | Ribosomal protein S2 | Cancer-related genes Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
RNF151 | Ring finger protein 151 | | | | | | Tissue enriched |
TBL3 | Transducin (beta)-like 3 | | | | | | Expressed in all |
NOXO1 | NADPH oxidase organizer 1 | FDA approved drug targets
| | | | | Tissue enhanced |
AC005606.1 | LOC283868 protein; Uncharacterized protein | | | | | | Tissue enriched |
GFER | Growth factor, augmenter of liver regeneration | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
SYNGR3 | Synaptogyrin 3 | Predicted membrane proteins
| | | | | Group enriched |
ZNF598 | Zinc finger protein 598 | | | | | | Expressed in all |
NPW | Neuropeptide W | Predicted secreted proteins
| | | | | Tissue enhanced |
SLC9A3R2 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 | Transporters
| | | | | Mixed |
NTHL1 | Nth endonuclease III-like 1 (E. coli) | Cancer-related genes Enzymes
| | | | | Expressed in all |
TSC2 | Tuberous sclerosis 2 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
PKD1 | Polycystic kidney disease 1 (autosomal dominant) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |